<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Genetic and metabolic disorders that may present with motor symptoms resembling cerebral palsy</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Genetic and metabolic disorders that may present with motor symptoms resembling cerebral palsy</h1>
<div class="graphic"><div class="figure"><div class="ttl">Genetic and metabolic disorders that may present with motor symptoms resembling cerebral palsy</div><div class="cntnt"><table cellspacing="0"><colgroup span="2" width="20%"></colgroup><colgroup span="2" width="30%"></colgroup> <tbody> <tr> <td class="subtitle1">Â </td> <td class="subtitle1">Type of motor disturbance</td> <td class="subtitle1">Clinical and radiographic features</td> <td class="subtitle1">Laboratory and diagnostic tests</td> </tr> <tr> <td class="subtitle2_left" colspan="4">Organic acidemias</td> </tr> <tr> <td class="indent1"><a href="http://omim.org/entry/231670" target="_blank">Glutaric aciduria type 1</a></td> <td>Dystonia</td> <td> <ul> <li>Episodes of metabolic decompensation and encephalopathy often precipitated by infection and fever</li> <li>Rarely presents in the newborn period</li> <li>Microencephalic macrocephaly</li> <li>Seizures (approximately 20%)</li> <li>Cognitive function is preserved</li> <li>MRI findings include frontal and temporal atrophy</li> </ul> </td> <td> <ul> <li>Abnormal urinary organic acid analysis (elevated glutaric acid and 3-hydroxyglutaric acid)</li> </ul> </td> </tr> <tr> <td class="indent1"><a href="http://omim.org/entry/253270" target="_blank">Holocarboxylase synthetase deficiency</a></td> <td>Hypotonia</td> <td> <ul> <li>Ketoacidosis</li> <li>Dermatitis</li> <li>Alopecia</li> <li>Seizures</li> <li>Developmental delay</li> </ul> </td> <td> <ul> <li>Abnormal urinary organic acid analysis (elevated beta-hydroxyisovalerate, beta-methylcrotonylglycine, beta-hydroxypropionate, methylcitrate, and tiglylglycine)</li> </ul> </td> </tr> <tr> <td class="subtitle2_left" colspan="4">Urea cycle disorders</td> </tr> <tr> <td class="indent1"><a href="http://omim.org/entry/207800" target="_blank">Arginase deficiency</a></td> <td>Spasticity</td> <td> <ul> <li>Hyperammonemia</li> <li>Encephalopathy</li> <li>Respiratory alkalosis</li> </ul> </td> <td> <ul> <li>Elevated ammonia level</li> <li>Abnormal quantitative plasma amino acid analysis (elevated arginine level)</li> </ul> </td> </tr> <tr> <td class="subtitle2_left" colspan="4">Disorders of carbohydrate metabolism</td> </tr> <tr> <td class="indent1"><a href="http://omim.org/entry/312170" target="_blank">Pyruvate dehydrogenase deficiency</a></td> <td> <p>Spasticity</p> <p>Ataxia</p> Hypotonia</td> <td> <ul> <li>Lactic acidosis</li> <li>Seizures</li> <li>Intellectual disability</li> </ul> </td> <td> <ul> <li>Elevated lactate and pyruvate levels in blood and CSF</li> <li>Abnormal PDH enzymatic activity in cultured fibroblasts</li> </ul> </td> </tr> <tr> <td class="subtitle2_left" colspan="4">Peroxisomal disorders</td> </tr> <tr> <td class="indent1"><a href="http://omim.org/entry/214100" target="_blank">Zellweger syndrome</a></td> <td>Hypotonia</td> <td> <ul> <li>Craniofacial dysmorphism</li> <li>Hepatomegaly</li> <li>Neonatal seizures</li> <li>Profound developmental delay</li> <li>MRI findings include cortical and white matter abnormalities</li> <li>Neurologic deterioration is rapid and infants rarely survive beyond six months of age</li> </ul> </td> <td> <ul> <li>Elevated plasma VLCFA levels</li> <li>Elevated levels of phytanic acid, pristanic acid, and pipecolic acid in plasma and fibroblasts</li> <li>Reduced plasmalogen in erythrocytes</li> <li>Molecular genetic testing for variants in the PEX1 or PEX6 genes may also be helpful</li> </ul> </td> </tr> <tr> <td class="indent1"><a href="http://omim.org/entry/300100" target="_blank">Adrenoleukodystrophy</a> and adrenomyeloneuropathy</td> <td>Spasticity</td> <td> <ul> <li>Clinical features vary by specific type, and may include: <ul> <li>Cognitive and behavioral abnormalities</li> <li>Adrenal insufficiency</li> <li>Hyperpigmented skin</li> <li>Gonadal dysfunction</li> <li>Neurologic deterioration progresses at a variable rate</li> </ul> </li> </ul> </td> <td> <ul> <li>Elevated plasma VLCFA levels</li> <li>Molecular genetic testing for variants in the ABCD1 gene may be helpful in cases with borderline VLCFA levels or atypical features, or in females</li> </ul> </td> </tr> <tr> <td class="indent1"><a href="http://omim.org/entry/601539" target="_blank">Infantile Refsum disease</a></td> <td> <p>Hypotonia</p> Ataxia</td> <td> <ul> <li>Abnormalities of the optic nerve and disc</li> <li>Retinitis pigmentosa</li> <li>Sensorineural hearing loss</li> <li>Hepatomegaly and cirrhosis</li> <li>Neurologic deterioration is slower than in Zellweger syndrome or ALD</li> </ul> </td> <td> <ul> <li>Elevated plasma VLCFA levels, though less pronounced than in Zellweger syndrome and ALD</li> </ul> </td> </tr> <tr> <td class="subtitle2_left" colspan="4">Lipid storage disorders</td> </tr> <tr> <td class="indent1"><a href="http://omim.org/entry/257220" target="_blank">Niemann-Pick disease type C</a></td> <td> <p>Ataxia</p> Dystonia</td> <td> <ul> <li>Progressive neurodegeneration</li> <li>Hepatosplenomegaly</li> <li>Systemic involvement of liver, spleen, or lung precedes neurologic symptoms</li> <li>MRI shows cerebral and cerebellar atrophy and thinning of the corpus callosum</li> </ul> </td> <td> <ul> <li>Abnormal liver function tests</li> <li>Fibroblast cell culture with filipin staining</li> </ul> </td> </tr> <tr> <td class="subtitle2_left" colspan="4">Mitochondrial disorders</td> </tr> <tr> <td class="indent1"><a href="http://www.omim.org/entry/256000" target="_blank">Leigh syndrome</a></td> <td> <p>Ataxia</p> Dystonia</td> <td> <ul> <li>Progressive psychomotor regression</li> <li>Seizures</li> <li>External ophthalmoplegia</li> <li>Lactic acidosis</li> <li>Vomiting</li> <li>MRI shows abnormal white matter signal in the putamen, basal ganglia, and brainstem on T2 images</li> </ul> </td> <td> <ul> <li>Increased lactate levels in blood and CSF</li> <li>Genetic testing for specific variants (&gt;20 have been described)</li> </ul> </td> </tr> <tr> <td class="subtitle2_left" colspan="4">Others</td> </tr> <tr> <td class="indent1"><a href="http://omim.org/entry/105830" target="_blank">Angelman syndrome</a></td> <td>Ataxia</td> <td> <ul> <li>Profound intellectual disability</li> <li>Postnatal microcephaly</li> <li>Typical abnormal behaviors (paroxysmal laughter, easily excitable)</li> </ul> </td> <td> <ul> <li>Methylation studies and chromosome microarray to detect chromosome 15 anomalies and UBE3A genetic variants</li> </ul> </td> </tr> <tr> <td class="indent1"><a href="http://omim.org/entry/208900" target="_blank">Ataxia-telangiectasia</a></td> <td>Ataxia</td> <td> <ul> <li>Progressive cerebellar ataxia</li> <li>Abnormal eye movements</li> <li>Oculocutaneous telangiectasias</li> <li>Immune deficiency</li> <li>Increased risk of malignancy</li> </ul> </td> <td> <ul> <li>Elevated serum alpha-fetoprotein level</li> <li>Low IgA and IgG levels</li> <li>Lymphopenia</li> <li>Genetic testing for variants in the ATM gene</li> </ul> </td> </tr> <tr> <td class="indent1"><a href="https://omim.org/entry/160900" target="_blank">Congenital myotonic dystrophy</a></td> <td>Hypotonia</td> <td> <ul> <li>Facial diplegia</li> <li>Arthrogryposis</li> <li>Poor feeding</li> <li>Intellectual disability</li> </ul> </td> <td> <ul> <li>Genetic testing for DMPK variants</li> <li>Electromyography showing myotonic discharges</li> <li>Electrocardiography may show cardiac conduction abnormalities</li> </ul> </td> </tr> <tr> <td class="indent1"><a href="http://omim.org/entry/128230" target="_blank">Dopa-responsive dystonia</a></td> <td> <p>Focal dystonia</p> Spastic diplegia</td> <td> <ul> <li>Onset in early childhood</li> <li>Symptoms worsen with fatigue and exercise</li> </ul> </td> <td> <ul> <li>Positive response to a trial of levodopa</li> </ul> </td> </tr> <tr> <td class="indent1"><a href="http://omim.org/phenotypicSeries/PS303350" target="_blank">Hereditary spastic paraplegia</a></td> <td>Spastic paraplegia</td> <td> <ul> <li>Variable depending on specific genetic variant</li> </ul> </td> <td> <ul> <li>&gt;50 genetic variants have been identified</li> <li>Genetic testing is available for many</li> </ul> </td> </tr> <tr> <td class="indent1"><a href="http://omim.org/entry/300322" target="_blank">Lesch-Nyhan syndrome</a></td> <td> <p>Choreoathetosis</p> <p>Dystonia</p> Spasticity</td> <td> <ul> <li>Self-mutilating behavior</li> <li>Urinary stones due to hyperuricemia</li> </ul> </td> <td> <ul> <li>Elevated uric acid level</li> <li>Abnormal enzymatic activity of HPRT in cultured fibroblasts</li> <li>Genetic testing for HPRT variants</li> </ul> </td> </tr> <tr> <td class="indent1"><a href="http://omim.org/entry/250100" target="_blank">Metachromatic leukodystrophy</a></td> <td> <p>Hypotonia</p> Ataxia</td> <td> <ul> <li>Regression of motor skills</li> <li>Seizures</li> <li>Optic atrophy</li> <li>Reduced or absent deep tendon reflexes</li> <li>Intellectual disability</li> </ul> </td> <td> <ul> <li>Deficient arylsulfatase A enzyme activity in leukocytes or cultured skin fibroblasts</li> </ul> </td> </tr> <tr> <td class="indent1"><a href="http://omim.org/entry/247200" target="_blank">Miller-Dieker lissencephaly</a></td> <td>Hypotonia or spasticity</td> <td> <ul> <li>Lissencephaly</li> <li>Microcephaly</li> <li>Dysmorphic features</li> <li>Seizures</li> <li>Failure to thrive</li> </ul> </td> <td> <ul> <li>Cytogenetic testing for 17p13.3 microdeletion</li> </ul> </td> </tr> <tr> <td class="indent1"><a href="http://omim.org/entry/312080" target="_blank">Pelizaeus-Merzbacher</a></td> <td> <p>Spasticity</p> <p>Ataxia</p> Athetosis</td> <td> <ul> <li>Nystagmus</li> <li>Cognitive impairment</li> <li>Onset in infancy</li> <li>Slowly progressive</li> <li>Language development may be normal</li> <li>MRI shows white matter abnormalities</li> </ul> </td> <td> <ul> <li>Genetic testing for variants in PLP1 gene</li> </ul> </td> </tr> <tr> <td class="indent1"><a href="http://omim.org/entry/607596" target="_blank">Pontocerebellar hypoplasias</a></td> <td> <p>Hypotonia</p> Dyskinesias</td> <td> <ul> <li>Clinical features vary by specific type, and may include: <ul> <li>Progressive muscle atrophy</li> <li>Microcephaly</li> <li>Developmental delay</li> <li>MRI shows small cerebellum and brainstem including the pons</li> </ul> </li> </ul> </td> <td> <ul> <li>Genetic testing for PCH gene variants (variants in &gt;10 genes have been described)</li> </ul> </td> </tr> <tr> <td class="indent1"><a href="http://omim.org/entry/312750" target="_blank">Rett syndrome</a></td> <td> <p>Dystonia</p> Spasticity</td> <td> <ul> <li>Occurs almost exclusively in females</li> <li>Normal development during first six months followed by regression and loss of milestones</li> <li>Loss of speech capability</li> <li>Stereotypic hand movements</li> <li>Seizures</li> <li>Autistic features</li> </ul> </td> <td> <ul> <li>Clinical diagnosis</li> <li>Genetic testing for MECP2 variants may be helpful</li> </ul> </td> </tr> <tr> <td class="indent1"><a href="https://omim.org/entry/225750" target="_blank">Aicardi-Goutieres</a></td> <td> <p>Spasticity</p> Dystonia</td> <td> <ul> <li>Infantile spasms</li> <li>Abnormal eye movements</li> <li>Truncal hypotonia</li> <li>Intellectual disability</li> <li>MRI shows agenesis of the corpus callosum and calcifications of the basal ganglia and periventricular areas</li> </ul> </td> <td> <ul> <li>Lymphocytic pleocytosis in CSF</li> <li>Genetic testing for pathologic variants in TREX1</li> </ul> </td> </tr> </tbody></table></div><div class="graphic_lgnd">This list is not exhaustive. Refer to UpToDate topics on cerebral palsy for further details.</div><div class="graphic_footnotes">VLCFA: very long chain fatty acids; PDH: pyruvate dehydrogenase; HPRT: hypoxanthine phosphoribosyltransferase; CSF: cerebrospinal fluid; PCH: pontocerebellar hypoplasias; MRI: magnetic resonance imaging; Ig: immunoglobulin; ATM: ataxia-telangiectasia mutated; ALD: adrenoleukodystrophy.</div><div id="graphicVersion">Graphic 102942 Version 3.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
